Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Collagen supplement tested for younger-looking skin

NCT ID NCT07302789

Symptom relief Sponsor: Bionos Biotech S.L. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested whether taking a daily collagen peptide supplement for 8 weeks could improve skin beauty in healthy women aged 35-65 with visible wrinkles. 67 women took either the test supplement or a competitor's collagen product. Researchers measured skin elasticity, wrinkle depth, hydration, and barrier function at 4 and 8 weeks. The goal was to see if the supplement could reduce signs of aging.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Collagen peptides supplement (2,500 mg daily sachet)
What this could lead to
If it works, this could support using collagen supplements to improve skin appearance and hydration in aging women.
What could go wrong
This is a small, completed trial with no phase designation, so results may not be generalizable. The supplement is compared to another collagen product, not a placebo, and benefits may be modest or subjective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

67 people

The number who actually took part.

Started

Feb 2025

Finished

Apr 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy female volunteers. * Between 35-65 years old (both included). * With noticeable wrinkles (wrinkles in the crow's feet area). * Subjects with absence of any infectious disease within the 4 weeks previous to the study. * Informed of the purpose and the protocol of the study and signed a written informed-consent form. Exclusion Criteria: * Diagnosis of any diseases such as cardiovascular disease, chronic kidney disease (CKD), gastrointestinal disorder, endocrinological disorder, immunological disorder, metabolic disease. * Consume more than the recommended alcohol guidelines i.e. \>14 units/week for females (europa.eu). * Current smoking habit or history of smoking within the past 1 year. * History of depression, schizophrenia, alcoholism, drug addiction, or mental illness. * Current or previous intake of contraceptives, female hormones, obesity drugs, absorption inhibitors, antidepressants, or appetite suppressants. * History of asthma or autoimmune disease Use of oral hormone therapies ie. cortisone or steroids in the 6 months prior to initiation of the study. * Abnormal liver function or abnormal renal function. * Blood pressure \>140/90 mmHg or hypertension with intake of a diuretic. * Any condition judged by the investigator to be unsuitable for participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial wrinkles - rough texture - hyperpigmentation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Facial wrinkles - rough texture - hyperpigmentation Skin ageing Skin hydration in healthy volunteers

Contacts and locations

Locations

  • Bionos Biotech S.L., LabAnalysis Life Science

    Valencia, 46007, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.